KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Emergent BioSolutions (EBS) Long-Term Debt Issuances: 2011-2024

Historic Long-Term Debt Issuances for Emergent BioSolutions (EBS) over the last 2 years, with Sep 2024 value amounting to $154.0 million.

  • Emergent BioSolutions' Long-Term Debt Issuances was N/A to $154.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $239.0 million, marking a year-over-year change of. This contributed to the annual value of $219.0 million for FY2024, which is 995.00% up from last year.
  • Per Emergent BioSolutions' latest filing, its Long-Term Debt Issuances stood at $154.0 million for Q3 2024, which was up 926.67% from $15.0 million recorded in Q2 2024.
  • In the past 5 years, Emergent BioSolutions' Long-Term Debt Issuances ranged from a high of $360.0 million in Q4 2022 and a low of $15.0 million during Q2 2024.
  • Over the past 3 years, Emergent BioSolutions' median Long-Term Debt Issuances value was $50.0 million (recorded in 2024), while the average stood at $119.8 million.
  • Data for Emergent BioSolutions' Long-Term Debt Issuances shows a maximum YoY plummeted of 94.44% (in 2023) over the last 5 years.
  • Over the past 3 years, Emergent BioSolutions' Long-Term Debt Issuances (Quarterly) stood at $360.0 million in 2022, then slumped by 94.44% to $20.0 million in 2023, then reached $154.0 million in 2024.
  • Its last three reported values are $154.0 million in Q3 2024, $15.0 million for Q2 2024, and $50.0 million during Q1 2024.